nodes	percent_of_prediction	percent_of_DWPC	metapath
Irinotecan—lung cancer—sarcoma	0.205	1	CtDrD
Irinotecan—Topoisomerase Inhibitors—Mitoxantrone—sarcoma	0.197	0.354	CiPCiCtD
Irinotecan—Topoisomerase Inhibitors—Etoposide—sarcoma	0.155	0.278	CiPCiCtD
Irinotecan—Topoisomerase Inhibitors—Epirubicin—sarcoma	0.106	0.191	CiPCiCtD
Irinotecan—Topoisomerase Inhibitors—Doxorubicin—sarcoma	0.0984	0.177	CiPCiCtD
Irinotecan—ABCC1—Dactinomycin—sarcoma	0.0138	0.077	CbGbCtD
Irinotecan—CYP2B6—Thiotepa—sarcoma	0.0135	0.0755	CbGbCtD
Irinotecan—SLC22A3—Vincristine—sarcoma	0.013	0.0726	CbGbCtD
Irinotecan—ABCC1—Mitoxantrone—sarcoma	0.0124	0.0689	CbGbCtD
Irinotecan—ABCC1—Epirubicin—sarcoma	0.01	0.0558	CbGbCtD
Irinotecan—UGT1A1—Etoposide—sarcoma	0.0095	0.0529	CbGbCtD
Irinotecan—ABCG2—Dactinomycin—sarcoma	0.00926	0.0515	CbGbCtD
Irinotecan—ABCC1—Vincristine—sarcoma	0.00852	0.0474	CbGbCtD
Irinotecan—ABCG2—Mitoxantrone—sarcoma	0.00828	0.0461	CbGbCtD
Irinotecan—ABCC1—Etoposide—sarcoma	0.0078	0.0435	CbGbCtD
Irinotecan—ABCC2—Vincristine—sarcoma	0.0063	0.0351	CbGbCtD
Irinotecan—ABCC2—Etoposide—sarcoma	0.00578	0.0322	CbGbCtD
Irinotecan—ABCG2—Vincristine—sarcoma	0.0057	0.0317	CbGbCtD
Irinotecan—ABCC1—Doxorubicin—sarcoma	0.00532	0.0296	CbGbCtD
Irinotecan—ABCG2—Etoposide—sarcoma	0.00522	0.0291	CbGbCtD
Irinotecan—CYP3A7—Vincristine—sarcoma	0.00421	0.0234	CbGbCtD
Irinotecan—CYP3A7-CYP3A51P—Vincristine—sarcoma	0.00421	0.0234	CbGbCtD
Irinotecan—CYP3A4—Thiotepa—sarcoma	0.00416	0.0232	CbGbCtD
Irinotecan—ABCC2—Doxorubicin—sarcoma	0.00394	0.0219	CbGbCtD
Irinotecan—ABCG2—Doxorubicin—sarcoma	0.00356	0.0198	CbGbCtD
Irinotecan—ABCB1—Dactinomycin—sarcoma	0.00334	0.0186	CbGbCtD
Irinotecan—CYP3A5—Vincristine—sarcoma	0.00316	0.0176	CbGbCtD
Irinotecan—ABCB1—Mitoxantrone—sarcoma	0.00299	0.0166	CbGbCtD
Irinotecan—CYP3A5—Etoposide—sarcoma	0.00289	0.0161	CbGbCtD
Irinotecan—CYP2B6—Doxorubicin—sarcoma	0.00251	0.014	CbGbCtD
Irinotecan—ABCB1—Vincristine—sarcoma	0.00206	0.0114	CbGbCtD
Irinotecan—ABCB1—Etoposide—sarcoma	0.00188	0.0105	CbGbCtD
Irinotecan—CYP3A4—Mitoxantrone—sarcoma	0.00179	0.00997	CbGbCtD
Irinotecan—ABCB1—Doxorubicin—sarcoma	0.00128	0.00715	CbGbCtD
Irinotecan—CYP3A4—Vincristine—sarcoma	0.00123	0.00686	CbGbCtD
Irinotecan—CYP3A4—Etoposide—sarcoma	0.00113	0.00628	CbGbCtD
Irinotecan—CES1—larynx—sarcoma	0.00105	0.0682	CbGeAlD
Irinotecan—BCHE—diaphragm—sarcoma	0.000978	0.0634	CbGeAlD
Irinotecan—CYP3A4—Doxorubicin—sarcoma	0.00077	0.00429	CbGbCtD
Irinotecan—TOP1—mammary gland—sarcoma	0.000456	0.0296	CbGeAlD
Irinotecan—CES2—mammary gland—sarcoma	0.000414	0.0268	CbGeAlD
Irinotecan—TOP1—myometrium—sarcoma	0.000324	0.021	CbGeAlD
Irinotecan—CES2—myometrium—sarcoma	0.000294	0.019	CbGeAlD
Irinotecan—SLCO1B1—mammary gland—sarcoma	0.000293	0.019	CbGeAlD
Irinotecan—TOP1—seminal vesicle—sarcoma	0.000293	0.019	CbGeAlD
Irinotecan—TOP1MT—testis—sarcoma	0.000289	0.0187	CbGeAlD
Irinotecan—TOP1MT—liver—sarcoma	0.000273	0.0177	CbGeAlD
Irinotecan—CES2—seminal vesicle—sarcoma	0.000265	0.0172	CbGeAlD
Irinotecan—CES2—hematopoietic system—sarcoma	0.000252	0.0164	CbGeAlD
Irinotecan—TOP1—smooth muscle tissue—sarcoma	0.000245	0.0159	CbGeAlD
Irinotecan—ALB—mammary gland—sarcoma	0.000237	0.0154	CbGeAlD
Irinotecan—CES2—smooth muscle tissue—sarcoma	0.000222	0.0144	CbGeAlD
Irinotecan—CES2—skin of body—sarcoma	0.000219	0.0142	CbGeAlD
Irinotecan—UGT1A1—hematopoietic system—sarcoma	0.000214	0.0139	CbGeAlD
Irinotecan—TOP1—cardiac atrium—sarcoma	0.000211	0.0137	CbGeAlD
Irinotecan—TOP1—uterus—sarcoma	0.00021	0.0136	CbGeAlD
Irinotecan—TOP1MT—lymph node—sarcoma	0.000209	0.0136	CbGeAlD
Irinotecan—CES1—hematopoietic system—sarcoma	0.000208	0.0135	CbGeAlD
Irinotecan—CES1—connective tissue—sarcoma	0.0002	0.013	CbGeAlD
Irinotecan—CES2—cardiac atrium—sarcoma	0.000192	0.0124	CbGeAlD
Irinotecan—CES2—uterus—sarcoma	0.000191	0.0124	CbGeAlD
Irinotecan—TOP1—tendon—sarcoma	0.000184	0.0119	CbGeAlD
Irinotecan—SLCO1B1—hematopoietic system—sarcoma	0.000178	0.0116	CbGeAlD
Irinotecan—TOP1—bone marrow—sarcoma	0.000178	0.0116	CbGeAlD
Irinotecan—SLC22A3—myometrium—sarcoma	0.000168	0.0109	CbGeAlD
Irinotecan—CES2—tendon—sarcoma	0.000167	0.0108	CbGeAlD
Irinotecan—UGT1A9—liver—sarcoma	0.000162	0.0105	CbGeAlD
Irinotecan—CES2—bone marrow—sarcoma	0.000162	0.0105	CbGeAlD
Irinotecan—SLC22A3—embryo—sarcoma	0.000161	0.0105	CbGeAlD
Irinotecan—TOP1—testis—sarcoma	0.000152	0.00988	CbGeAlD
Irinotecan—SLC22A3—seminal vesicle—sarcoma	0.000152	0.00983	CbGeAlD
Irinotecan—CES1—lymphoid tissue—sarcoma	0.000146	0.00948	CbGeAlD
Irinotecan—SLC22A3—hematopoietic system—sarcoma	0.000144	0.00935	CbGeAlD
Irinotecan—TOP1—liver—sarcoma	0.000144	0.00934	CbGeAlD
Irinotecan—ABCC1—myometrium—sarcoma	0.000139	0.009	CbGeAlD
Irinotecan—SLC22A3—connective tissue—sarcoma	0.000139	0.009	CbGeAlD
Irinotecan—CES2—testis—sarcoma	0.000138	0.00896	CbGeAlD
Irinotecan—ACHE—tendon—sarcoma	0.000137	0.00891	CbGeAlD
Irinotecan—CYP3A7—liver—sarcoma	0.000135	0.00874	CbGeAlD
Irinotecan—CES2—liver—sarcoma	0.000131	0.00847	CbGeAlD
Irinotecan—SLC22A3—smooth muscle tissue—sarcoma	0.000127	0.00823	CbGeAlD
Irinotecan—ABCC1—seminal vesicle—sarcoma	0.000125	0.00813	CbGeAlD
Irinotecan—BCHE—myometrium—sarcoma	0.000119	0.00771	CbGeAlD
Irinotecan—ABCG2—myometrium—sarcoma	0.000115	0.00745	CbGeAlD
Irinotecan—CYP3A7-CYP3A51P—liver—sarcoma	0.000115	0.00743	CbGeAlD
Irinotecan—CES1—testis—sarcoma	0.000114	0.00738	CbGeAlD
Irinotecan—ACHE—testis—sarcoma	0.000114	0.00738	CbGeAlD
Irinotecan—UGT1A1—liver—sarcoma	0.000111	0.0072	CbGeAlD
Irinotecan—TOP1—lymph node—sarcoma	0.00011	0.00716	CbGeAlD
Irinotecan—CES1—liver—sarcoma	0.000108	0.00698	CbGeAlD
Irinotecan—BCHE—seminal vesicle—sarcoma	0.000107	0.00696	CbGeAlD
Irinotecan—ABCG2—seminal vesicle—sarcoma	0.000104	0.00673	CbGeAlD
Irinotecan—BCHE—hematopoietic system—sarcoma	0.000102	0.00662	CbGeAlD
Irinotecan—CES2—lymph node—sarcoma	0.0001	0.0065	CbGeAlD
Irinotecan—SLCO1B1—liver—sarcoma	9.25e-05	0.00599	CbGeAlD
Irinotecan—CYP3A5—hematopoietic system—sarcoma	9.16e-05	0.00594	CbGeAlD
Irinotecan—CYP2B6—hematopoietic system—sarcoma	9.1e-05	0.0059	CbGeAlD
Irinotecan—ABCC1—cardiac atrium—sarcoma	9.05e-05	0.00587	CbGeAlD
Irinotecan—ABCC1—uterus—sarcoma	9e-05	0.00584	CbGeAlD
Irinotecan—BCHE—smooth muscle tissue—sarcoma	8.99e-05	0.00583	CbGeAlD
Irinotecan—ABCC2—tendon—sarcoma	8.95e-05	0.00581	CbGeAlD
Irinotecan—BCHE—skin of body—sarcoma	8.88e-05	0.00575	CbGeAlD
Irinotecan—CES1—lymph node—sarcoma	8.25e-05	0.00535	CbGeAlD
Irinotecan—ACHE—lymph node—sarcoma	8.25e-05	0.00535	CbGeAlD
Irinotecan—CYP2B6—skin of body—sarcoma	7.91e-05	0.00513	CbGeAlD
Irinotecan—ALB—testis—sarcoma	7.91e-05	0.00513	CbGeAlD
Irinotecan—SLC22A3—testis—sarcoma	7.9e-05	0.00512	CbGeAlD
Irinotecan—ABCC1—tendon—sarcoma	7.89e-05	0.00511	CbGeAlD
Irinotecan—BCHE—cardiac atrium—sarcoma	7.75e-05	0.00503	CbGeAlD
Irinotecan—BCHE—uterus—sarcoma	7.71e-05	0.005	CbGeAlD
Irinotecan—ALB—liver—sarcoma	7.48e-05	0.00485	CbGeAlD
Irinotecan—SLC22A3—liver—sarcoma	7.47e-05	0.00484	CbGeAlD
Irinotecan—ABCG2—uterus—sarcoma	7.45e-05	0.00483	CbGeAlD
Irinotecan—ABCC2—testis—sarcoma	7.41e-05	0.00481	CbGeAlD
Irinotecan—ABCC2—liver—sarcoma	7.01e-05	0.00454	CbGeAlD
Irinotecan—CYP3A4—hematopoietic system—sarcoma	6.87e-05	0.00446	CbGeAlD
Irinotecan—BCHE—bone marrow—sarcoma	6.54e-05	0.00424	CbGeAlD
Irinotecan—ABCC1—testis—sarcoma	6.53e-05	0.00423	CbGeAlD
Irinotecan—CYP2B6—lymphoid tissue—sarcoma	6.41e-05	0.00416	CbGeAlD
Irinotecan—ABCG2—bone marrow—sarcoma	6.33e-05	0.0041	CbGeAlD
Irinotecan—ABCC1—liver—sarcoma	6.17e-05	0.004	CbGeAlD
Irinotecan—ALB—lymph node—sarcoma	5.74e-05	0.00372	CbGeAlD
Irinotecan—SLC22A3—lymph node—sarcoma	5.73e-05	0.00371	CbGeAlD
Irinotecan—ABCB1—myometrium—sarcoma	5.67e-05	0.00367	CbGeAlD
Irinotecan—BCHE—testis—sarcoma	5.59e-05	0.00363	CbGeAlD
Irinotecan—ABCB1—embryo—sarcoma	5.45e-05	0.00353	CbGeAlD
Irinotecan—ABCG2—testis—sarcoma	5.41e-05	0.00351	CbGeAlD
Irinotecan—ABCC2—lymph node—sarcoma	5.37e-05	0.00348	CbGeAlD
Irinotecan—BCHE—liver—sarcoma	5.29e-05	0.00343	CbGeAlD
Irinotecan—ABCB1—seminal vesicle—sarcoma	5.12e-05	0.00332	CbGeAlD
Irinotecan—ABCG2—liver—sarcoma	5.11e-05	0.00331	CbGeAlD
Irinotecan—CYP2B6—testis—sarcoma	4.99e-05	0.00323	CbGeAlD
Irinotecan—ABCB1—hematopoietic system—sarcoma	4.87e-05	0.00315	CbGeAlD
Irinotecan—CYP3A5—liver—sarcoma	4.75e-05	0.00308	CbGeAlD
Irinotecan—ABCC1—lymph node—sarcoma	4.73e-05	0.00307	CbGeAlD
Irinotecan—CYP2B6—liver—sarcoma	4.72e-05	0.00306	CbGeAlD
Irinotecan—Malaise—Etoposide—sarcoma	4.51e-05	0.00103	CcSEcCtD
Irinotecan—Vertigo—Etoposide—sarcoma	4.5e-05	0.00102	CcSEcCtD
Irinotecan—Body temperature increased—Thiotepa—sarcoma	4.5e-05	0.00102	CcSEcCtD
Irinotecan—Abdominal pain—Thiotepa—sarcoma	4.5e-05	0.00102	CcSEcCtD
Irinotecan—Leukopenia—Etoposide—sarcoma	4.48e-05	0.00102	CcSEcCtD
Irinotecan—Abdominal pain—Dactinomycin—sarcoma	4.46e-05	0.00102	CcSEcCtD
Irinotecan—Body temperature increased—Dactinomycin—sarcoma	4.46e-05	0.00102	CcSEcCtD
Irinotecan—Anaphylactoid reaction—Doxorubicin—sarcoma	4.45e-05	0.00101	CcSEcCtD
Irinotecan—Cardiac arrest—Epirubicin—sarcoma	4.43e-05	0.00101	CcSEcCtD
Irinotecan—Paraesthesia—Mitoxantrone—sarcoma	4.41e-05	0.001	CcSEcCtD
Irinotecan—Loss of consciousness—Etoposide—sarcoma	4.4e-05	0.001	CcSEcCtD
Irinotecan—Cerebrovascular accident—Doxorubicin—sarcoma	4.4e-05	0.001	CcSEcCtD
Irinotecan—Decreased appetite—Vincristine—sarcoma	4.38e-05	0.000999	CcSEcCtD
Irinotecan—Dyspnoea—Mitoxantrone—sarcoma	4.38e-05	0.000998	CcSEcCtD
Irinotecan—Cough—Etoposide—sarcoma	4.37e-05	0.000995	CcSEcCtD
Irinotecan—Somnolence—Mitoxantrone—sarcoma	4.37e-05	0.000995	CcSEcCtD
Irinotecan—Blood creatinine increased—Epirubicin—sarcoma	4.36e-05	0.000994	CcSEcCtD
Irinotecan—Gastrointestinal disorder—Vincristine—sarcoma	4.35e-05	0.000992	CcSEcCtD
Irinotecan—Fatigue—Vincristine—sarcoma	4.35e-05	0.000991	CcSEcCtD
Irinotecan—Dehydration—Epirubicin—sarcoma	4.33e-05	0.000987	CcSEcCtD
Irinotecan—Hyponatraemia—Doxorubicin—sarcoma	4.33e-05	0.000986	CcSEcCtD
Irinotecan—Dyspepsia—Mitoxantrone—sarcoma	4.32e-05	0.000985	CcSEcCtD
Irinotecan—Hypertension—Etoposide—sarcoma	4.32e-05	0.000985	CcSEcCtD
Irinotecan—Pain—Vincristine—sarcoma	4.31e-05	0.000982	CcSEcCtD
Irinotecan—Constipation—Vincristine—sarcoma	4.31e-05	0.000982	CcSEcCtD
Irinotecan—Gastrointestinal haemorrhage—Doxorubicin—sarcoma	4.31e-05	0.000982	CcSEcCtD
Irinotecan—Osteoarthritis—Doxorubicin—sarcoma	4.31e-05	0.000982	CcSEcCtD
Irinotecan—Decreased appetite—Mitoxantrone—sarcoma	4.27e-05	0.000973	CcSEcCtD
Irinotecan—Orthostatic hypotension—Epirubicin—sarcoma	4.26e-05	0.000969	CcSEcCtD
Irinotecan—Hypokalaemia—Epirubicin—sarcoma	4.24e-05	0.000966	CcSEcCtD
Irinotecan—Fatigue—Mitoxantrone—sarcoma	4.23e-05	0.000965	CcSEcCtD
Irinotecan—Discomfort—Etoposide—sarcoma	4.21e-05	0.000959	CcSEcCtD
Irinotecan—Constipation—Mitoxantrone—sarcoma	4.2e-05	0.000957	CcSEcCtD
Irinotecan—Pain—Mitoxantrone—sarcoma	4.2e-05	0.000957	CcSEcCtD
Irinotecan—Aspartate aminotransferase increased—Epirubicin—sarcoma	4.2e-05	0.000956	CcSEcCtD
Irinotecan—Hypersensitivity—Thiotepa—sarcoma	4.19e-05	0.000955	CcSEcCtD
Irinotecan—Hypersensitivity—Dactinomycin—sarcoma	4.16e-05	0.000947	CcSEcCtD
Irinotecan—Gastrointestinal pain—Vincristine—sarcoma	4.12e-05	0.000939	CcSEcCtD
Irinotecan—Confusional state—Etoposide—sarcoma	4.12e-05	0.000938	CcSEcCtD
Irinotecan—Cardiac arrest—Doxorubicin—sarcoma	4.1e-05	0.000934	CcSEcCtD
Irinotecan—Anaphylactic shock—Etoposide—sarcoma	4.09e-05	0.000931	CcSEcCtD
Irinotecan—Asthenia—Thiotepa—sarcoma	4.08e-05	0.00093	CcSEcCtD
Irinotecan—Infection—Etoposide—sarcoma	4.06e-05	0.000925	CcSEcCtD
Irinotecan—BCHE—lymph node—sarcoma	4.06e-05	0.00263	CbGeAlD
Irinotecan—Abdominal distension—Epirubicin—sarcoma	4.05e-05	0.000924	CcSEcCtD
Irinotecan—Asthenia—Dactinomycin—sarcoma	4.05e-05	0.000923	CcSEcCtD
Irinotecan—Feeling abnormal—Mitoxantrone—sarcoma	4.05e-05	0.000922	CcSEcCtD
Irinotecan—Blood creatinine increased—Doxorubicin—sarcoma	4.04e-05	0.00092	CcSEcCtD
Irinotecan—Gastrointestinal pain—Mitoxantrone—sarcoma	4.02e-05	0.000915	CcSEcCtD
Irinotecan—Dehydration—Doxorubicin—sarcoma	4.01e-05	0.000913	CcSEcCtD
Irinotecan—Thrombocytopenia—Etoposide—sarcoma	4e-05	0.000911	CcSEcCtD
Irinotecan—Abdominal pain—Vincristine—sarcoma	3.99e-05	0.000908	CcSEcCtD
Irinotecan—Body temperature increased—Vincristine—sarcoma	3.99e-05	0.000908	CcSEcCtD
Irinotecan—Hyperhidrosis—Etoposide—sarcoma	3.95e-05	0.0009	CcSEcCtD
Irinotecan—Pancreatitis—Epirubicin—sarcoma	3.95e-05	0.000899	CcSEcCtD
Irinotecan—Orthostatic hypotension—Doxorubicin—sarcoma	3.94e-05	0.000897	CcSEcCtD
Irinotecan—Hypokalaemia—Doxorubicin—sarcoma	3.92e-05	0.000894	CcSEcCtD
Irinotecan—Angina pectoris—Epirubicin—sarcoma	3.92e-05	0.000894	CcSEcCtD
Irinotecan—ABCG2—lymph node—sarcoma	3.92e-05	0.00254	CbGeAlD
Irinotecan—Anorexia—Etoposide—sarcoma	3.89e-05	0.000887	CcSEcCtD
Irinotecan—Diarrhoea—Thiotepa—sarcoma	3.89e-05	0.000887	CcSEcCtD
Irinotecan—Abdominal pain—Mitoxantrone—sarcoma	3.88e-05	0.000885	CcSEcCtD
Irinotecan—Body temperature increased—Mitoxantrone—sarcoma	3.88e-05	0.000885	CcSEcCtD
Irinotecan—Aspartate aminotransferase increased—Doxorubicin—sarcoma	3.88e-05	0.000884	CcSEcCtD
Irinotecan—Diarrhoea—Dactinomycin—sarcoma	3.86e-05	0.00088	CcSEcCtD
Irinotecan—Hypotension—Etoposide—sarcoma	3.82e-05	0.00087	CcSEcCtD
Irinotecan—Neutropenia—Epirubicin—sarcoma	3.77e-05	0.000858	CcSEcCtD
Irinotecan—Dizziness—Thiotepa—sarcoma	3.76e-05	0.000857	CcSEcCtD
Irinotecan—Abdominal distension—Doxorubicin—sarcoma	3.75e-05	0.000855	CcSEcCtD
Irinotecan—Upper respiratory tract infection—Epirubicin—sarcoma	3.74e-05	0.000853	CcSEcCtD
Irinotecan—Hypersensitivity—Vincristine—sarcoma	3.72e-05	0.000846	CcSEcCtD
Irinotecan—ABCB1—uterus—sarcoma	3.68e-05	0.00238	CbGeAlD
Irinotecan—Paraesthesia—Etoposide—sarcoma	3.67e-05	0.000836	CcSEcCtD
Irinotecan—Pancreatitis—Doxorubicin—sarcoma	3.65e-05	0.000832	CcSEcCtD
Irinotecan—Weight decreased—Epirubicin—sarcoma	3.64e-05	0.00083	CcSEcCtD
Irinotecan—Dyspnoea—Etoposide—sarcoma	3.64e-05	0.00083	CcSEcCtD
Irinotecan—Somnolence—Etoposide—sarcoma	3.63e-05	0.000827	CcSEcCtD
Irinotecan—Angina pectoris—Doxorubicin—sarcoma	3.63e-05	0.000827	CcSEcCtD
Irinotecan—Hypersensitivity—Mitoxantrone—sarcoma	3.62e-05	0.000824	CcSEcCtD
Irinotecan—Asthenia—Vincristine—sarcoma	3.62e-05	0.000824	CcSEcCtD
Irinotecan—Vomiting—Thiotepa—sarcoma	3.62e-05	0.000824	CcSEcCtD
Irinotecan—Pneumonia—Epirubicin—sarcoma	3.61e-05	0.000823	CcSEcCtD
Irinotecan—Vomiting—Dactinomycin—sarcoma	3.59e-05	0.000818	CcSEcCtD
Irinotecan—Rash—Thiotepa—sarcoma	3.59e-05	0.000817	CcSEcCtD
Irinotecan—Dermatitis—Thiotepa—sarcoma	3.58e-05	0.000816	CcSEcCtD
Irinotecan—Headache—Thiotepa—sarcoma	3.56e-05	0.000812	CcSEcCtD
Irinotecan—CYP3A4—liver—sarcoma	3.56e-05	0.00231	CbGeAlD
Irinotecan—Rash—Dactinomycin—sarcoma	3.56e-05	0.000811	CcSEcCtD
Irinotecan—Decreased appetite—Etoposide—sarcoma	3.55e-05	0.000809	CcSEcCtD
Irinotecan—Renal failure—Epirubicin—sarcoma	3.53e-05	0.000804	CcSEcCtD
Irinotecan—Gastrointestinal disorder—Etoposide—sarcoma	3.53e-05	0.000804	CcSEcCtD
Irinotecan—Asthenia—Mitoxantrone—sarcoma	3.52e-05	0.000803	CcSEcCtD
Irinotecan—Fatigue—Etoposide—sarcoma	3.52e-05	0.000802	CcSEcCtD
Irinotecan—Stomatitis—Epirubicin—sarcoma	3.5e-05	0.000797	CcSEcCtD
Irinotecan—Jaundice—Epirubicin—sarcoma	3.5e-05	0.000797	CcSEcCtD
Irinotecan—Pain—Etoposide—sarcoma	3.49e-05	0.000796	CcSEcCtD
Irinotecan—Constipation—Etoposide—sarcoma	3.49e-05	0.000796	CcSEcCtD
Irinotecan—Neutropenia—Doxorubicin—sarcoma	3.48e-05	0.000794	CcSEcCtD
Irinotecan—Upper respiratory tract infection—Doxorubicin—sarcoma	3.46e-05	0.000789	CcSEcCtD
Irinotecan—Diarrhoea—Vincristine—sarcoma	3.45e-05	0.000786	CcSEcCtD
Irinotecan—Sweating—Epirubicin—sarcoma	3.44e-05	0.000784	CcSEcCtD
Irinotecan—ABCB1—lymphoid tissue—sarcoma	3.43e-05	0.00222	CbGeAlD
Irinotecan—Nausea—Thiotepa—sarcoma	3.38e-05	0.00077	CcSEcCtD
Irinotecan—Weight decreased—Doxorubicin—sarcoma	3.37e-05	0.000768	CcSEcCtD
Irinotecan—Feeling abnormal—Etoposide—sarcoma	3.37e-05	0.000767	CcSEcCtD
Irinotecan—Diarrhoea—Mitoxantrone—sarcoma	3.36e-05	0.000766	CcSEcCtD
Irinotecan—Nausea—Dactinomycin—sarcoma	3.35e-05	0.000764	CcSEcCtD
Irinotecan—Pneumonia—Doxorubicin—sarcoma	3.34e-05	0.000761	CcSEcCtD
Irinotecan—Gastrointestinal pain—Etoposide—sarcoma	3.34e-05	0.000761	CcSEcCtD
Irinotecan—Dizziness—Vincristine—sarcoma	3.33e-05	0.00076	CcSEcCtD
Irinotecan—Bradycardia—Epirubicin—sarcoma	3.28e-05	0.000748	CcSEcCtD
Irinotecan—Renal failure—Doxorubicin—sarcoma	3.27e-05	0.000744	CcSEcCtD
Irinotecan—Haemoglobin—Epirubicin—sarcoma	3.24e-05	0.000738	CcSEcCtD
Irinotecan—Stomatitis—Doxorubicin—sarcoma	3.24e-05	0.000738	CcSEcCtD
Irinotecan—Jaundice—Doxorubicin—sarcoma	3.24e-05	0.000738	CcSEcCtD
Irinotecan—Rhinitis—Epirubicin—sarcoma	3.23e-05	0.000736	CcSEcCtD
Irinotecan—Body temperature increased—Etoposide—sarcoma	3.23e-05	0.000736	CcSEcCtD
Irinotecan—Abdominal pain—Etoposide—sarcoma	3.23e-05	0.000736	CcSEcCtD
Irinotecan—Haemorrhage—Epirubicin—sarcoma	3.22e-05	0.000734	CcSEcCtD
Irinotecan—Vomiting—Vincristine—sarcoma	3.21e-05	0.00073	CcSEcCtD
Irinotecan—Sweating—Doxorubicin—sarcoma	3.18e-05	0.000726	CcSEcCtD
Irinotecan—Rash—Vincristine—sarcoma	3.18e-05	0.000724	CcSEcCtD
Irinotecan—Dermatitis—Vincristine—sarcoma	3.18e-05	0.000724	CcSEcCtD
Irinotecan—Connective tissue disorder—Epirubicin—sarcoma	3.17e-05	0.000722	CcSEcCtD
Irinotecan—Headache—Vincristine—sarcoma	3.16e-05	0.00072	CcSEcCtD
Irinotecan—Vomiting—Mitoxantrone—sarcoma	3.12e-05	0.000711	CcSEcCtD
Irinotecan—ABCB1—bone marrow—sarcoma	3.12e-05	0.00202	CbGeAlD
Irinotecan—Visual impairment—Epirubicin—sarcoma	3.11e-05	0.000708	CcSEcCtD
Irinotecan—Rash—Mitoxantrone—sarcoma	3.1e-05	0.000705	CcSEcCtD
Irinotecan—Dermatitis—Mitoxantrone—sarcoma	3.09e-05	0.000705	CcSEcCtD
Irinotecan—Headache—Mitoxantrone—sarcoma	3.08e-05	0.000701	CcSEcCtD
Irinotecan—Bradycardia—Doxorubicin—sarcoma	3.04e-05	0.000692	CcSEcCtD
Irinotecan—Hypersensitivity—Etoposide—sarcoma	3.01e-05	0.000686	CcSEcCtD
Irinotecan—Haemoglobin—Doxorubicin—sarcoma	3e-05	0.000683	CcSEcCtD
Irinotecan—Nausea—Vincristine—sarcoma	3e-05	0.000682	CcSEcCtD
Irinotecan—Flushing—Epirubicin—sarcoma	2.99e-05	0.000682	CcSEcCtD
Irinotecan—Cardiac disorder—Epirubicin—sarcoma	2.99e-05	0.000682	CcSEcCtD
Irinotecan—Rhinitis—Doxorubicin—sarcoma	2.99e-05	0.000681	CcSEcCtD
Irinotecan—Haemorrhage—Doxorubicin—sarcoma	2.98e-05	0.000679	CcSEcCtD
Irinotecan—Asthenia—Etoposide—sarcoma	2.93e-05	0.000668	CcSEcCtD
Irinotecan—Connective tissue disorder—Doxorubicin—sarcoma	2.93e-05	0.000668	CcSEcCtD
Irinotecan—Angiopathy—Epirubicin—sarcoma	2.92e-05	0.000666	CcSEcCtD
Irinotecan—Nausea—Mitoxantrone—sarcoma	2.92e-05	0.000665	CcSEcCtD
Irinotecan—Immune system disorder—Epirubicin—sarcoma	2.91e-05	0.000663	CcSEcCtD
Irinotecan—Mediastinal disorder—Epirubicin—sarcoma	2.9e-05	0.000662	CcSEcCtD
Irinotecan—Chills—Epirubicin—sarcoma	2.89e-05	0.000659	CcSEcCtD
Irinotecan—Arrhythmia—Epirubicin—sarcoma	2.88e-05	0.000656	CcSEcCtD
Irinotecan—Visual impairment—Doxorubicin—sarcoma	2.87e-05	0.000655	CcSEcCtD
Irinotecan—Alopecia—Epirubicin—sarcoma	2.85e-05	0.000649	CcSEcCtD
Irinotecan—Diarrhoea—Etoposide—sarcoma	2.79e-05	0.000637	CcSEcCtD
Irinotecan—Flushing—Doxorubicin—sarcoma	2.77e-05	0.000631	CcSEcCtD
Irinotecan—Cardiac disorder—Doxorubicin—sarcoma	2.77e-05	0.000631	CcSEcCtD
Irinotecan—Flatulence—Epirubicin—sarcoma	2.76e-05	0.00063	CcSEcCtD
Irinotecan—Back pain—Epirubicin—sarcoma	2.71e-05	0.000618	CcSEcCtD
Irinotecan—Angiopathy—Doxorubicin—sarcoma	2.71e-05	0.000616	CcSEcCtD
Irinotecan—Dizziness—Etoposide—sarcoma	2.7e-05	0.000615	CcSEcCtD
Irinotecan—Muscle spasms—Epirubicin—sarcoma	2.7e-05	0.000615	CcSEcCtD
Irinotecan—Immune system disorder—Doxorubicin—sarcoma	2.69e-05	0.000614	CcSEcCtD
Irinotecan—Mediastinal disorder—Doxorubicin—sarcoma	2.69e-05	0.000612	CcSEcCtD
Irinotecan—Chills—Doxorubicin—sarcoma	2.68e-05	0.00061	CcSEcCtD
Irinotecan—ABCB1—testis—sarcoma	2.67e-05	0.00173	CbGeAlD
Irinotecan—Arrhythmia—Doxorubicin—sarcoma	2.66e-05	0.000607	CcSEcCtD
Irinotecan—Alopecia—Doxorubicin—sarcoma	2.64e-05	0.0006	CcSEcCtD
Irinotecan—Ill-defined disorder—Epirubicin—sarcoma	2.6e-05	0.000593	CcSEcCtD
Irinotecan—Vomiting—Etoposide—sarcoma	2.6e-05	0.000592	CcSEcCtD
Irinotecan—Anaemia—Epirubicin—sarcoma	2.59e-05	0.000591	CcSEcCtD
Irinotecan—Rash—Etoposide—sarcoma	2.58e-05	0.000587	CcSEcCtD
Irinotecan—Dermatitis—Etoposide—sarcoma	2.57e-05	0.000586	CcSEcCtD
Irinotecan—Headache—Etoposide—sarcoma	2.56e-05	0.000583	CcSEcCtD
Irinotecan—Flatulence—Doxorubicin—sarcoma	2.56e-05	0.000583	CcSEcCtD
Irinotecan—Malaise—Epirubicin—sarcoma	2.53e-05	0.000576	CcSEcCtD
Irinotecan—Vertigo—Epirubicin—sarcoma	2.52e-05	0.000574	CcSEcCtD
Irinotecan—ABCB1—liver—sarcoma	2.52e-05	0.00163	CbGeAlD
Irinotecan—Syncope—Epirubicin—sarcoma	2.52e-05	0.000573	CcSEcCtD
Irinotecan—Leukopenia—Epirubicin—sarcoma	2.51e-05	0.000572	CcSEcCtD
Irinotecan—Back pain—Doxorubicin—sarcoma	2.51e-05	0.000572	CcSEcCtD
Irinotecan—Muscle spasms—Doxorubicin—sarcoma	2.5e-05	0.000569	CcSEcCtD
Irinotecan—Loss of consciousness—Epirubicin—sarcoma	2.47e-05	0.000562	CcSEcCtD
Irinotecan—Cough—Epirubicin—sarcoma	2.45e-05	0.000558	CcSEcCtD
Irinotecan—Nausea—Etoposide—sarcoma	2.43e-05	0.000553	CcSEcCtD
Irinotecan—Hypertension—Epirubicin—sarcoma	2.42e-05	0.000552	CcSEcCtD
Irinotecan—Ill-defined disorder—Doxorubicin—sarcoma	2.41e-05	0.000549	CcSEcCtD
Irinotecan—Anaemia—Doxorubicin—sarcoma	2.4e-05	0.000547	CcSEcCtD
Irinotecan—Discomfort—Epirubicin—sarcoma	2.36e-05	0.000538	CcSEcCtD
Irinotecan—Malaise—Doxorubicin—sarcoma	2.34e-05	0.000533	CcSEcCtD
Irinotecan—Vertigo—Doxorubicin—sarcoma	2.33e-05	0.000531	CcSEcCtD
Irinotecan—Syncope—Doxorubicin—sarcoma	2.33e-05	0.00053	CcSEcCtD
Irinotecan—Leukopenia—Doxorubicin—sarcoma	2.32e-05	0.000529	CcSEcCtD
Irinotecan—Confusional state—Epirubicin—sarcoma	2.31e-05	0.000526	CcSEcCtD
Irinotecan—Oedema—Epirubicin—sarcoma	2.29e-05	0.000522	CcSEcCtD
Irinotecan—Anaphylactic shock—Epirubicin—sarcoma	2.29e-05	0.000522	CcSEcCtD
Irinotecan—Loss of consciousness—Doxorubicin—sarcoma	2.28e-05	0.00052	CcSEcCtD
Irinotecan—Infection—Epirubicin—sarcoma	2.27e-05	0.000518	CcSEcCtD
Irinotecan—Cough—Doxorubicin—sarcoma	2.27e-05	0.000516	CcSEcCtD
Irinotecan—Shock—Epirubicin—sarcoma	2.25e-05	0.000513	CcSEcCtD
Irinotecan—Nervous system disorder—Epirubicin—sarcoma	2.25e-05	0.000512	CcSEcCtD
Irinotecan—Thrombocytopenia—Epirubicin—sarcoma	2.24e-05	0.000511	CcSEcCtD
Irinotecan—Hypertension—Doxorubicin—sarcoma	2.24e-05	0.000511	CcSEcCtD
Irinotecan—Hyperhidrosis—Epirubicin—sarcoma	2.21e-05	0.000504	CcSEcCtD
Irinotecan—Discomfort—Doxorubicin—sarcoma	2.18e-05	0.000498	CcSEcCtD
Irinotecan—Anorexia—Epirubicin—sarcoma	2.18e-05	0.000497	CcSEcCtD
Irinotecan—Hypotension—Epirubicin—sarcoma	2.14e-05	0.000487	CcSEcCtD
Irinotecan—Confusional state—Doxorubicin—sarcoma	2.14e-05	0.000487	CcSEcCtD
Irinotecan—Anaphylactic shock—Doxorubicin—sarcoma	2.12e-05	0.000483	CcSEcCtD
Irinotecan—Oedema—Doxorubicin—sarcoma	2.12e-05	0.000483	CcSEcCtD
Irinotecan—Infection—Doxorubicin—sarcoma	2.1e-05	0.00048	CcSEcCtD
Irinotecan—Shock—Doxorubicin—sarcoma	2.08e-05	0.000475	CcSEcCtD
Irinotecan—Nervous system disorder—Doxorubicin—sarcoma	2.08e-05	0.000473	CcSEcCtD
Irinotecan—Thrombocytopenia—Doxorubicin—sarcoma	2.07e-05	0.000473	CcSEcCtD
Irinotecan—Insomnia—Epirubicin—sarcoma	2.07e-05	0.000472	CcSEcCtD
Irinotecan—Paraesthesia—Epirubicin—sarcoma	2.06e-05	0.000468	CcSEcCtD
Irinotecan—Hyperhidrosis—Doxorubicin—sarcoma	2.05e-05	0.000467	CcSEcCtD
Irinotecan—Dyspnoea—Epirubicin—sarcoma	2.04e-05	0.000465	CcSEcCtD
Irinotecan—Somnolence—Epirubicin—sarcoma	2.04e-05	0.000464	CcSEcCtD
Irinotecan—Anorexia—Doxorubicin—sarcoma	2.02e-05	0.00046	CcSEcCtD
Irinotecan—Dyspepsia—Epirubicin—sarcoma	2.02e-05	0.000459	CcSEcCtD
Irinotecan—Decreased appetite—Epirubicin—sarcoma	1.99e-05	0.000454	CcSEcCtD
Irinotecan—Hypotension—Doxorubicin—sarcoma	1.98e-05	0.000451	CcSEcCtD
Irinotecan—Gastrointestinal disorder—Epirubicin—sarcoma	1.98e-05	0.00045	CcSEcCtD
Irinotecan—Fatigue—Epirubicin—sarcoma	1.97e-05	0.00045	CcSEcCtD
Irinotecan—Pain—Epirubicin—sarcoma	1.96e-05	0.000446	CcSEcCtD
Irinotecan—Constipation—Epirubicin—sarcoma	1.96e-05	0.000446	CcSEcCtD
Irinotecan—ABCB1—lymph node—sarcoma	1.93e-05	0.00125	CbGeAlD
Irinotecan—Insomnia—Doxorubicin—sarcoma	1.92e-05	0.000437	CcSEcCtD
Irinotecan—Paraesthesia—Doxorubicin—sarcoma	1.9e-05	0.000433	CcSEcCtD
Irinotecan—Dyspnoea—Doxorubicin—sarcoma	1.89e-05	0.00043	CcSEcCtD
Irinotecan—Feeling abnormal—Epirubicin—sarcoma	1.89e-05	0.00043	CcSEcCtD
Irinotecan—Somnolence—Doxorubicin—sarcoma	1.88e-05	0.000429	CcSEcCtD
Irinotecan—Gastrointestinal pain—Epirubicin—sarcoma	1.87e-05	0.000427	CcSEcCtD
Irinotecan—Dyspepsia—Doxorubicin—sarcoma	1.87e-05	0.000425	CcSEcCtD
Irinotecan—Decreased appetite—Doxorubicin—sarcoma	1.84e-05	0.00042	CcSEcCtD
Irinotecan—Gastrointestinal disorder—Doxorubicin—sarcoma	1.83e-05	0.000417	CcSEcCtD
Irinotecan—Fatigue—Doxorubicin—sarcoma	1.83e-05	0.000416	CcSEcCtD
Irinotecan—Pain—Doxorubicin—sarcoma	1.81e-05	0.000413	CcSEcCtD
Irinotecan—Constipation—Doxorubicin—sarcoma	1.81e-05	0.000413	CcSEcCtD
Irinotecan—Body temperature increased—Epirubicin—sarcoma	1.81e-05	0.000412	CcSEcCtD
Irinotecan—Abdominal pain—Epirubicin—sarcoma	1.81e-05	0.000412	CcSEcCtD
Irinotecan—Feeling abnormal—Doxorubicin—sarcoma	1.75e-05	0.000398	CcSEcCtD
Irinotecan—Gastrointestinal pain—Doxorubicin—sarcoma	1.73e-05	0.000395	CcSEcCtD
Irinotecan—Hypersensitivity—Epirubicin—sarcoma	1.69e-05	0.000384	CcSEcCtD
Irinotecan—Abdominal pain—Doxorubicin—sarcoma	1.67e-05	0.000382	CcSEcCtD
Irinotecan—Body temperature increased—Doxorubicin—sarcoma	1.67e-05	0.000382	CcSEcCtD
Irinotecan—Asthenia—Epirubicin—sarcoma	1.64e-05	0.000374	CcSEcCtD
Irinotecan—Diarrhoea—Epirubicin—sarcoma	1.57e-05	0.000357	CcSEcCtD
Irinotecan—Hypersensitivity—Doxorubicin—sarcoma	1.56e-05	0.000356	CcSEcCtD
Irinotecan—Asthenia—Doxorubicin—sarcoma	1.52e-05	0.000346	CcSEcCtD
Irinotecan—Dizziness—Epirubicin—sarcoma	1.51e-05	0.000345	CcSEcCtD
Irinotecan—Vomiting—Epirubicin—sarcoma	1.46e-05	0.000332	CcSEcCtD
Irinotecan—Diarrhoea—Doxorubicin—sarcoma	1.45e-05	0.00033	CcSEcCtD
Irinotecan—Rash—Epirubicin—sarcoma	1.44e-05	0.000329	CcSEcCtD
Irinotecan—Dermatitis—Epirubicin—sarcoma	1.44e-05	0.000329	CcSEcCtD
Irinotecan—Headache—Epirubicin—sarcoma	1.43e-05	0.000327	CcSEcCtD
Irinotecan—Dizziness—Doxorubicin—sarcoma	1.4e-05	0.000319	CcSEcCtD
Irinotecan—Nausea—Epirubicin—sarcoma	1.36e-05	0.00031	CcSEcCtD
Irinotecan—Vomiting—Doxorubicin—sarcoma	1.35e-05	0.000307	CcSEcCtD
Irinotecan—Rash—Doxorubicin—sarcoma	1.34e-05	0.000304	CcSEcCtD
Irinotecan—Dermatitis—Doxorubicin—sarcoma	1.33e-05	0.000304	CcSEcCtD
Irinotecan—Headache—Doxorubicin—sarcoma	1.33e-05	0.000302	CcSEcCtD
Irinotecan—Nausea—Doxorubicin—sarcoma	1.26e-05	0.000287	CcSEcCtD
